Test Price
2,800 AED✅ Home Collection Available
SCN5A Gene Long QT Syndrome Type 3 (LQT3) Genetic Test in UAE | DHA & PDPL Compliant
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Hospital-Grade ISO Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance with result interpretation by a Consultant Medical Geneticist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This SCN5A gene sequencing test identifies pathogenic variants causing Long QT Syndrome Type 3 (LQT3), a cardiac channelopathy linked to life-threatening arrhythmias such as Torsades de Pointes and ventricular fibrillation. Early molecular diagnosis enables targeted therapy selection, risk stratification, and cascade screening for at-risk family members.
| Feature | Our SCN5A Test | Closest Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with full gene coverage, confirmed by Sanger sequencing | Single-site genotyping or limited hot-spot panel |
| Turnaround Time | 3–4 Weeks (ISO 9001:2015 accredited facility) | 4–6 Weeks (overseas reference laboratory) |
| Regulatory Compliance | DHA/MOHAP, Federal Decree-Law No. 45 of 2021 (PDPL), Federal Law No. 2 of 2019 | Variable, often non-UAE compliant |
Physician Insight & Safety Protocols
"Genetic results for cardiac channelopathies must be interpreted within the scope of a comprehensive clinical evaluation, including ECG findings, electrolyte panels, and a three-generation family history. Never discontinue or adjust prescribed beta-blockers or antiarrhythmic therapy without direct consultation with your treating cardiologist." — Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Medication Maintenance Advisory
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of beta-blockers or antiarrhythmics can trigger fatal arrhythmias and sudden cardiac arrest.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent blood transfusion (<4 weeks) may affect germline DNA analysis; must be reported during pre-test counseling.
- Exclusion: Minors require legal guardian consent as per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability and PDPL.
- Emergency Red Flags: If you experience syncope, palpitations, or seizure-like episodes before result reporting, seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the SCN5A Long QT syndrome type 3 genetic test?
This test directly identifies pathogenic mutations in the SCN5A gene to confirm a diagnosis of LQT3, guide therapy selection (such as mexiletine), enable family cascade screening, and prevent sudden cardiac death through early intervention.
2. How is the test performed and what sample types are accepted?
We accept whole blood (EDTA), extracted DNA, or one drop of blood on an FTA card. Our home collection team follows ISO-certified cold-chain procedures to ensure sample integrity from collection to laboratory processing.
3. What is the turnaround time for results?
The standard turnaround time is 3 to 4 weeks from the date the sample is received in our ISO 9001:2015 accredited laboratory located in Dubai Healthcare City.
4. Is this test covered by insurance in the UAE?
Many UAE insurers cover genetic testing for cardiac channelopathies when deemed medically necessary by a specialist. Our team verifies direct billing eligibility via WhatsApp at +971 54 548 8731, ensuring full compliance with UAE PDPL.
UAE Regulatory & Data Privacy Adherence
Your data is protected under: Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic information is encrypted, access-restricted, and processed solely for diagnostic purposes under the direct supervision of a licensed DHA facility.
Clinical & Logistical Metadata
| Test Name | SCN5A Gene Long QT Syndrome Type 3 (LQT3) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | I45.82 |
| LOINC Code | 83134-6 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians